Site Search

... and death by improving access to care and reducing tobacco use. Advocates asked lawmakers to support legislation that would improve access to biomarker testing, a game changer in the fight against cancer and an essential step in accessing precision medicine treatments by ensuring state-regulated health insurance, including Medicaid, covers appropriate biomarker testing for patients who could benefit. Dubbed ‘the right treatment at the right time,’ precision medicine has played a critical role ...

FRANKFORT, KY – Today, the General Assembly passed legislation that will increase access to biomarker testing, which can help determine the best treatment plan for a specific patient. Despite its benefits, private health insurance and Medicaid coverage of biomarker testing have not kept pace with the rate of innovation. This legislation, House Bill 180, fixes that barrier to access for many ...

... Assembly was supporting HCR 35 and SCR 29 which, if adopted, would allow for an auditor study to assess health insurance coverage for biomarker testing for Hawaii residents. Currently, insurance coverage for biomarker testing is failing to keep pace with innovation and advancement in treatment. Progress in improving cancer outcomes increasingly involves ...

... February 22, 2024 – A new paper released today in the Journal of Clinical Oncology    finds that while incorporating pharmacogenomic (PGx) testing into cancer care can help improve patient outcomes, barriers to PGx testing, discovery, and implementation are impacting its adoption and ... from them.” ACS CAN is working to improve access to PGx testing through its state advocacy work to expand insurance coverage of comprehensive biomarker testing, which includes PGx testing. Biomarker testing is a critical step toward accessing precision medicine, including targeted therapies; however, not all patients who could benefit ...